CRS + HIPEC

Cytoreductive surgery (CRS) and hyperthermia intraperitoneal chemotherapy (HIPEC) can have a strong influence on the overall and disease-free survival of various tumor entities in chosen patients with peritoneal surface tumors (PSM).